| Catalog No. | VK565026 |
| Host species | Human |
| Species reactivity | SARS-CoV-2 (2019-nCoV) |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | P0DTC2 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Anti-SARS-CoV-2 (2019-nCoV) RBD Reference Antibody (Cilgavimab, RUO)
Overview
Images
 SEC-HPLC |
SEC-HPLC detection for Research Grade Cilgavimab. |
 Bioactivity |
Detects Omicron RBD in indirect ELISAs. |
 SDS-PAGE |
SDS-PAGE for Research Grade Cilgavimab. |